C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, Long-term impacts of antibiotic exposure on the human intestinal microbiota, Microbiology, vol.156, pp.3216-3239, 2010.

L. Dethlefsen and D. A. Relman, Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation, Proc Natl Acad Sci U S A, vol.108, issue.1, pp.4554-61, 2011.

A. E. Pérez-cobas, M. J. Gosalbes, and A. Friedrichs, Gut microbiota disturbance during antibiotic therapy: a multiomic approach, Gut, vol.62, pp.1591-601, 2013.

Y. Belkaid and T. W. Hand, Role of the microbiota in immunity and inflammation, Cell, vol.157, pp.121-162, 2014.

L. M. Cox and M. J. Blaser, Antibiotics in early life and obesity, Nat Rev Endocrinol, vol.11, pp.182-90, 2015.

V. De-lastours and B. Fantin, Resistance to fluoroquinolones in 2010: what are the consequences for prescriptions in intensive care units?, Réanimation, vol.19, pp.347-53, 2010.

P. A. Johanesen, K. E. Mackin, and M. L. Hutton, Disruption of the gut microbiome: Clostridium difficile infection and the threat of antibiotic resistance, Genes (Basel), vol.6, pp.1347-60, 2015.

D. A. Leffler and J. T. Lamont, Clostridium difficile infection, N Engl J Med, vol.372, pp.1539-1587, 2015.

K. A. Brown, N. Khanafer, N. Daneman, and D. N. Fisman, Metaanalysis of antibiotics and the risk of community-associated Clostridium difficile infection, Antimicrob Agents Chemother, vol.57, pp.2326-2358, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02401778

A. Deshpande, V. Pasupuleti, and P. Thota, Communityassociated Clostridium difficile infection and antibiotics: a meta-analysis, J Antimicrob Chemother, vol.68, pp.1951-61, 2013.

C. Slimings and T. V. Riley, Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis, J Antimicrob Chemother, vol.69, pp.881-91, 2014.

S. V. Lynch and O. Pedersen, The human intestinal microbiome in health and disease, N Engl J Med, vol.375, pp.2369-79, 2016.

H. K. Pedersen, V. Gudmundsdottir, and H. B. Nielsen, MetaHIT Consortium. Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, vol.535, pp.376-81, 2016.

L. M. Cox, S. Yamanishi, and J. Sohn, Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences, Cell, vol.158, pp.705-726, 2014.

L. Chatelier, E. Nielsen, T. Qin, and J. , MetaHIT Consortium. Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, pp.541-547, 2013.

F. Léonard, A. Andremont, B. Leclerq, R. Labia, and C. Tancrède, Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization, J Infect Dis, vol.160, pp.274-80, 1989.

U. Stiefel, N. J. Pultz, and J. Harmoinen, Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice, J Infect Dis, vol.188, pp.1605-1614, 2003.

U. Stiefel, M. M. Nerandzic, P. Koski, and C. J. Donskey, Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile, J Antimicrob Chemother, vol.62, pp.1105-1113, 2008.

J. Pitout, IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora, Curr Opin Investig Drugs Lond Engl, vol.10, pp.838-882, 2000.

S. Connelly, J. A. Bristol, and S. Hubert, SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model, J Appl Microbiol, 2017.

M. Khoder, N. Tsapis, V. Domergue-dupont, C. Gueutin, and E. Fattal, Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads, Eur J Pharm Sci, vol.41, pp.281-289, 2010.

J. De-gunzburg, A. Ducher, and C. Modess, Targeted adsorption of molecules in the colon with the novel adsorbent-based medicinal product, DAV132: a proof of concept study in healthy subjects, J Clin Pharmacol, vol.55, pp.10-16, 2015.

C. Edlund, G. Beyer, M. Hiemer-bau, S. Ziege, H. Lode et al., Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora, Scand J Infect Dis, vol.32, pp.81-86, 2000.

J. J. Godon, E. Zumstein, P. Dabert, F. Habouzit, and R. Moletta, Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis

, Appl Environ Microbiol, vol.63, pp.2802-2815, 1997.

A. Suau, R. Bonnet, and M. Sutren, Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut, Appl Environ Microbiol, vol.65, pp.4799-807, 1999.

H. B. Nielsen, M. Almeida, and A. S. Juncker, MetaHIT Consortium; MetaHIT Consortium. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes, Nat Biotechnol, vol.32, pp.822-830, 2014.

A. Cotillard, S. P. Kennedy, and L. C. Kong, ANR MicroObes consortium. Dietary intervention impact on gut microbial gene richness, Nature, vol.500, pp.585-593, 2013.

B. Langmead, Aligning short sequencing reads with Bowtie, Curr Protoc Bioinforma, 2010.

M. D. Kitzis, . Antibiotic-assay, . Antibiogram, P. Courvalin, R. Leclerc et al., , 2010.

H. Stass, D. Kubitza, J. G. Möller, and H. Delesen, Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males, Br J Clin Pharmacol, vol.59, pp.536-577, 2005.

D. I. Andersson and D. Hughes, Microbiological effects of sublethal levels of antibiotics, Nat Rev Microbiol, vol.12, pp.465-78, 2014.

B. Fantin, X. Duval, and L. Massias, Ciprofloxacin dosage and emergence of resistance in human commensal bacteria, J Infect Dis, vol.200, pp.390-398, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00409776

C. Burdet, S. Sayah-jeanne, and T. T. Nguyen, Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced Clostridium difficile colitis, Antimicrob Agents Chemother, vol.61, pp.543-560, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01590774